Role of Tyrosine Kinase in Infection Immunity
Role of Tyrosine Kinase in Infection Immunity
批准号:
09836007
负责人:
MORIKAWA Yuko
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To elucidate the function of tyrosine kinase Pyk2 in the activation of T cells, we established Jurkat transfectants overexpressing wild-type Pyk2, Pyk2 lacking 50 amino acids in its proline-rich domain, kinase-inactive Pyk2, and Pyk2 with amino acid substitution (^<402>Tyr-Phe or ^<881>Tyr-Phe).We investigated activities of MAP kinase, JNK and p38 kinase and IL-2 production after stimulation of these Jurkat transfectants by crosslinking of both T-cell antigen receptor and CD28.The results indicated that Pyk2 is involved in the IL-2 production through activation of JNK, and that both the kinase activity and the N-terminal tyrosine (^<402>Tyr) are indispensable for the production of IL-2.We found that Pyk2 is physically associated with Vav.As Vav is shown to have GEF activity for Rac and activation of Rac leads to activation of JNK, this finding may explain how JNK is activated by Pyk2.We further established WEHI231 (immature B cell) transfectants overexpressing either wild-type or kinase-inactive Pyk2, and analyzed the activation of MAP kinase, JNK and p38 kinase in these transfectants upon simulation with 1 mM H_20_2.The results demonstrated that Pyk2 is also involved in the oxigen stress-induced activation of JNK but not in the induction of apoptosis.We established experimental conditions for infection of MAIDS virus or Salmonella in Fyn- or Chk-knock out mice, respectively, and now are investigating abnormalities in immune system of these mutant mice after the infection.The chemokine receptor CXCR4 is expressed on the immature thymocytes.We found that Pyk2 is activated in Jurkat T cells after stimulation of CXCR4 with its ligand SDF-1.To clarify the role of Pyk2 and CXCR4, we are preparing transgenic mice which overexpress the dominant negative form of Pyk2 specifically in T cells by using a lck promotor-containing expression vector.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K.Sato,K.Katagiri,S.Hattri,T.Tsuji,S.Irimura,S.Irie.& T.Katagiri.: "Laminin 5 promoters the activation and apotosis of T cells expressing α3β1 integrin" Exp.Cell Res.in press. (1999)
K. Sato、K. Katagiri、S. Hattri、T. Tsuji、S. Irimura、S. Irie. 和 T. Katagiri.:“层粘连蛋白 5 促进表达 α3β1 整合素的 T 细胞的激活和凋亡”Exp.Cell Res。正在出版(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Baba, Y.Kikuchi, S.Mori, H.Kimoto, S.Inui, et al: "Mouse germinal center B cells with the xid mutation retain responsiveness to anti-mouse CD40 antibodies but diminish IL-5 responsiveness" Int. Immunol. 9. 1463-1473 (1997)
M.Baba、Y.Kikuchi、S.Mori、H.Kimoto、S.Inui 等人:“具有 xid 突变的小鼠生发中心 B 细胞保留了对抗小鼠 CD40 抗体的反应性,但减弱了 IL-5 反应性”Int。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Kojima, F.Konishi, T.Tsukamoto, K.Yamashita, and K.Kanazawa: "Ki-raspoint mutaion in different types of colorectal carcinomas in early stages" Dis.Colon Rectum. 40. 151-167 (1997)
M.Kojima、F.Konishi、T.Tsukamoto、K.Yamashita 和 K.Kanazawa:“早期不同类型结直肠癌中的 Ki-raspoint 突变”Dis.Colon 直肠。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Katagiri, H.Yokosawa, T.Kinashi, S.Kawashima, S.Irie, T.Katagiri, et al: "Ubiquitin-proteasome system is involved in the induction of LFA-1/ICAM-1-dependent adhesion of HL-60 cells" J.Leukocyte Biol.in press. (1999)
K.Katagiri、H.Yokosawa、T.Kinashi、S.Kawashima、S.Irie、T.Katagiri 等人:“泛素蛋白酶体系统参与诱导 LFA-1/ICAM-1 依赖的 HL 粘附
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Tsukamoto, Y.Shibagaki, Y.Niikura, & K.Mizumoto: "Cloning and characterization of three human cDNAs encoding mRNA(guanine-7-)methyltransferase, an mRNA cap methylase" Biochem.Biophys.Res.Commun.251. 27-34 (1998)
T.Tsukamoto、Y.Shibagaki、Y.Niikura、
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 29 条
The determinants of health literacy and social capital among workers and those effects on health
-
批准号:18K10093
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2018
-
负责人:MORIKAWA Yuko
-
依托单位:
Molecular modification for MHC class I and II antigen presentation
-
批准号:24659211
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:MORIKAWA Yuko
-
依托单位:
Live-cell imaging of HIV replication component trafficking and assembly
-
批准号:22390091
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:MORIKAWA Yuko
-
依托单位:
A study on the relation of shift work on hormonal change and diseases of prostate
-
批准号:22590557
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:MORIKAWA Yuko
-
依托单位:
Follow-up study on adjustment to night and shift work ; a year follow up for sleep, fatigue and biomarkers
-
批准号:19590603
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2007
-
负责人:MORIKAWA Yuko
-
依托单位:
Identification of host factors responsible for virus paraticle production and screening of its inhibitors through yeast CytoTrap system
-
批准号:18390144
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.9万
-
财政年份:2006
-
负责人:MORIKAWA Yuko
-
依托单位:
Effect of night and shift work on glucose tolerance-circadian rhythm of glucose tolerance and insulin resistance
-
批准号:16590520
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:MORIKAWA Yuko
-
依托单位:
Identification of Host Factors for Virus Particle Release Based on Yeast Genetics
-
批准号:15390152
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.34万
-
财政年份:2003
-
负责人:MORIKAWA Yuko
-
依托单位:
Effects of Night Work on the Immune Function
-
批准号:14570362
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2002
-
负责人:MORIKAWA Yuko
-
依托单位:
Non-infectious virus particle budding by yeast spheroplasts
-
批准号:13670307
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:MORIKAWA Yuko
-
依托单位:
In vitro maturation of human immunodeficiency virus type 1 Gag virus-like particle
-
批准号:11670309
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:MORIKAWA Yuko
-
依托单位:
A cohort study on the_effect of shift work on the onset of circulatory diseases
-
批准号:09670418
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:MORIKAWA Yuko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Pyk2 磷酸化修饰转运蛋白 MCU 诱导线粒体铁超载介导
ELABELA/APJ 系统促血小板迁移
-
批准号:2024JJ9390
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:熊国祚
-
依托单位:
ELABELA/APJ 通过激活 Pyk2 磷酸化修饰 MCU 诱导线粒体铁超载促血小板聚集
-
批准号:2022JJ40379
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:蒋进勇
-
依托单位:
巨噬细胞迁移体通过FAK/Pyk2调控糖尿病肾病肾小管上皮细胞焦亡的机制研究
-
批准号:82260145
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:严瑞
-
依托单位:
酪氨酸激酶Pyk2调控核内DNA识别受体hnRNPA2B1介导的抗病毒天然免疫反应的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:温明岳
-
依托单位:
基质硬度微环境中TMEM237调控NPHP1/Pyk2/ERK信号通路促进肝癌进展的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:窦常伟
-
依托单位:
缺氧诱导的TMEM237调节NPHP1/Pyk2/ERK通路促进肝癌进展的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王亮
-
依托单位:
栝楼桂枝颗粒通过蛋白酪氨酸激酶Src/Pyk2调控NMDA受体复合物干预脑卒中后肢体痉挛的机制研究
-
批准号:2022J01861
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:韩静
-
依托单位:
Pyk2/Nrf2在AngII-ROS诱导的HSC-LX2焦亡中的调控及合欢皮-白蒺藜药对的干预作用
-
批准号:LY21H280003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:姚立
-
依托单位:
酪氨酸激酶Pyk2调控谷氨酸受体复合物引起学习记忆障碍的分子机制研究
-
批准号:31900692
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:李传洲
-
依托单位:
mGR/Pyk2/TRPM8通路介导精神应激致结肠内脏高敏感的机制研究
-
批准号:81970472
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:颜秀娟
-
依托单位: